3.38
price down icon0.88%   -0.03
after-market Handel nachbörslich: 3.32 -0.06 -1.78%
loading
Schlusskurs vom Vortag:
$3.41
Offen:
$3.42
24-Stunden-Volumen:
914.51K
Relative Volume:
0.73
Marktkapitalisierung:
$584.19M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-54.70M
KGV:
-10.24
EPS:
-0.33
Netto-Cashflow:
$-51.36M
1W Leistung:
-1.46%
1M Leistung:
-5.06%
6M Leistung:
+16.55%
1J Leistung:
-7.65%
1-Tages-Spanne:
Value
$3.36
$3.47
1-Wochen-Bereich:
Value
$3.34
$3.53
52-Wochen-Spanne:
Value
$1.89
$4.295

Savara Inc Stock (SVRA) Company Profile

Name
Firmenname
Savara Inc
Name
Telefon
51285113796
Name
Adresse
6836 BEE CAVE ROAD, AUSTIN, TX
Name
Mitarbeiter
59
Name
Twitter
@SavaraPharma
Name
Nächster Verdiensttermin
2025-03-26
Name
Neueste SEC-Einreichungen
Name
SVRA's Discussions on Twitter

Vergleichen Sie SVRA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
SVRA
Savara Inc
3.38 589.37M 0 -54.70M -51.36M -0.33
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
412.22 104.45B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
469.36 60.95B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.60 59.11B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
812.95 49.23B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.94 35.92B 4.56B -176.77M 225.30M -1.7177

Savara Inc Stock (SVRA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-08-15 Hochstufung H.C. Wainwright Neutral → Buy
2025-05-29 Herabstufung H.C. Wainwright Buy → Neutral
2024-12-20 Eingeleitet Wells Fargo Overweight
2024-11-13 Herabstufung Evercore ISI Outperform → In-line
2024-02-15 Eingeleitet JMP Securities Mkt Outperform
2023-11-07 Eingeleitet Guggenheim Buy
2023-05-16 Hochstufung Jefferies Hold → Buy
2023-03-31 Herabstufung Jefferies Buy → Hold
2021-03-16 Eingeleitet Piper Sandler Overweight
2021-03-15 Eingeleitet Oppenheimer Outperform
2019-06-13 Bestätigt H.C. Wainwright Buy
2019-06-13 Herabstufung JMP Securities Mkt Outperform → Mkt Perform
2019-06-13 Herabstufung Ladenburg Thalmann Buy → Neutral
2018-08-13 Fortgesetzt ROTH Capital Neutral
2018-01-03 Eingeleitet Ladenburg Thalmann Buy
2017-09-27 Fortgesetzt ROTH Capital Buy
2017-09-22 Eingeleitet Jefferies Buy
2017-09-11 Eingeleitet JMP Securities Mkt Outperform
Alle ansehen

Savara Inc Aktie (SVRA) Neueste Nachrichten

pulisher
Oct 13, 2025

Savara Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsSVRA - MarketScreener

Oct 13, 2025
pulisher
Oct 13, 2025

SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire

Oct 13, 2025
pulisher
Oct 13, 2025

Class Action Filed Against Savara Inc. (SVRA) Seeking Recovery for Investors – Contact The Gross Law Firm - GlobeNewswire

Oct 13, 2025
pulisher
Oct 13, 2025

Class Action Filed Against Savara Inc. (SVRA) Seeking Recovery for Investors – Contact The Gross Law Firm - GlobeNewswire Inc.

Oct 13, 2025
pulisher
Oct 13, 2025

Pomerantz Law Firm Announces the Filing of a Class Action Against Savara Inc. and Certain OfficersSVRA - PR Newswire

Oct 13, 2025
pulisher
Oct 13, 2025

November 7, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against SVRA - MarketScreener

Oct 13, 2025
pulisher
Oct 12, 2025

Did You Lose Money on Savara Inc. (SVRA)? Levi & Korsinsky Urges Investors to Act Before November 7, 2025 - ACCESS Newswire

Oct 12, 2025
pulisher
Oct 12, 2025

Securities Fraud Class Action Filed Against Savara Inc. (SVRA)Levi & Korsinsky Reminds Investors of November 7, 2025 - ACCESS Newswire

Oct 12, 2025
pulisher
Oct 12, 2025

November 7, 2025 Deadline Approaching: Join Class Action Against Savara Inc. (SVRA)Contact Levi & Korsinsky - ACCESS Newswire

Oct 12, 2025
pulisher
Oct 12, 2025

SVRA INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - GlobeNewswire

Oct 12, 2025
pulisher
Oct 10, 2025

SAVARA ALERT: Bragar Eagel & Squire, P.C. Urges Investors - GlobeNewswire

Oct 10, 2025
pulisher
Oct 10, 2025

SVRA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Oct 10, 2025
pulisher
Oct 10, 2025

How to forecast Savara Inc. trends using time series2025 Stock Rankings & Free Verified High Yield Trade Plans - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Burned by Savara Inc.? Contact Levi & Korsinsky to SueWallSt And Fight Back - ACCESS Newswire

Oct 09, 2025
pulisher
Oct 09, 2025

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - PR Newswire

Oct 09, 2025
pulisher
Oct 09, 2025

Shareholders that lost money on Savara Inc.(SVRA) Urged to - GlobeNewswire

Oct 09, 2025
pulisher
Oct 09, 2025

Shareholders that lost money on Savara Inc.(SVRA) should contact The Gross Law Firm about pending Class ActionSVRA - Morningstar

Oct 09, 2025
pulisher
Oct 09, 2025

Savara: Back On Track With Upcoming APAP BLA Filing (NASDAQ:SVRA) - Seeking Alpha

Oct 09, 2025
pulisher
Oct 09, 2025

Weiss Ratings Reaffirms Sell (D-) Rating for Savara (NASDAQ:SVRA) - Defense World

Oct 09, 2025
pulisher
Oct 08, 2025

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Savara Inc. - GlobeNewswire

Oct 08, 2025
pulisher
Oct 08, 2025

Savara Inc. INVESTOR ALERT: Kirby McInerney LLP Reminds - GlobeNewswire

Oct 08, 2025
pulisher
Oct 08, 2025

Savara Inc. INVESTOR ALERT: Kirby McInerney LLP Reminds Savara Inc. Investors of Looming Lead ... - Bluefield Daily Telegraph

Oct 08, 2025
pulisher
Oct 08, 2025

Savara Inc. INVESTOR ALERT: Kirby McInerney LLP Reminds Savara Inc. Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuit | Franklin Credit Management Corporation - FinancialContent

Oct 08, 2025
pulisher
Oct 08, 2025

SVRA DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - GlobeNewswire

Oct 08, 2025
pulisher
Oct 07, 2025

SVRA Investors Have Opportunity to Lead Savara Inc. Securities F - GuruFocus

Oct 07, 2025
pulisher
Oct 07, 2025

SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit - Your Wyoming Link

Oct 07, 2025
pulisher
Oct 07, 2025

Savara Inc. (SVRA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire

Oct 07, 2025
pulisher
Oct 07, 2025

Lost Money on Savara Inc. (SVRA)? Urged to Join Class Action Before November 7, 2025Contact Levi & Korsinsky - ACCESS Newswire

Oct 07, 2025
pulisher
Oct 07, 2025

Lost Money on Savara Inc. (SVRA)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - GlobeNewswire

Oct 07, 2025
pulisher
Oct 06, 2025

Securities Lawsuit Alert: Savara Inc. (SVRA)Contact Levi & Korsinsky Before November 7, 2025 - ACCESS Newswire

Oct 06, 2025
pulisher
Oct 06, 2025

Deadline Alert: Savara Inc. (SVRA) Shareholders Who Lost - GlobeNewswire

Oct 06, 2025
pulisher
Oct 06, 2025

SAVARA CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. - GlobeNewswire

Oct 06, 2025
pulisher
Oct 06, 2025

SVRA LAWSUIT ALERT: Levi & Korsinsky Notifies Savara Inc. InvestorsLead Plaintiff Deadline November 7, 2025 - ACCESS Newswire

Oct 06, 2025
pulisher
Oct 06, 2025

About Us - FinancialContent

Oct 06, 2025
pulisher
Oct 06, 2025

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of November 7, 2025 in Savara Inc. LawsuitSVRA - Morningstar

Oct 06, 2025
pulisher
Oct 05, 2025

Savara Inc. $SVRA Position Increased by Farther Finance Advisors LLC - Defense World

Oct 05, 2025
pulisher
Oct 05, 2025

Levi & Korsinsky Urges Savara Inc. (SVRA) Shareholders to Act Before Lead Plaintiff Deadline November 7, 2025 - ACCESS Newswire

Oct 05, 2025
pulisher
Oct 04, 2025

Bragar Eagel & Squire, P.C. Urges Investors of Tronox, - GlobeNewswire

Oct 04, 2025
pulisher
Oct 04, 2025

Faruqi & Faruqi Reminds Savara Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 7, 2025SVRA - Newsfile

Oct 04, 2025
pulisher
Oct 03, 2025

Levi & Korsinsky Helps Shareholders SueWallSt After Savara Inc. Stock Drops - ACCESS Newswire

Oct 03, 2025
pulisher
Oct 03, 2025

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - MarketScreener

Oct 03, 2025
pulisher
Oct 03, 2025

Quantitative breakdown of Savara Inc. recent moveLong Setup & Fast Entry and Exit Trade Plans - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

What indicators show strength in Savara Inc.Insider Buying & Comprehensive Market Scan Insights - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Savara Announces Encore Presentations of Results From the Phase 3 IMPALA-2 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at CHEST 2025 - BioSpace

Oct 03, 2025
pulisher
Oct 02, 2025

Why Savara Inc. stock could benefit from AI revolution2025 Key Lessons & Fast Exit and Entry Trade Guides - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

Savara Inc. stock trend outlook and recovery pathProduct Launch & Real-Time Stock Movement Alerts - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

SVRA NOTICE: Savara Inc. Investors Urged to Contact Kirby McInerney LLP About Securities Fraud Lawsuit - GlobeNewswire

Oct 02, 2025
pulisher
Oct 02, 2025

MarketsMedicine Hat News - FinancialContent

Oct 02, 2025
pulisher
Oct 02, 2025

Savara to present aPAP diagnosis test data at CHEST 2025 - Investing.com

Oct 02, 2025
pulisher
Oct 02, 2025

Savara (SVRA) to Showcase Research at CHEST 2025 Conference - GuruFocus

Oct 02, 2025
pulisher
Oct 02, 2025

Savara to present aPAP diagnosis test data at CHEST 2025 By Investing.com - Investing.com Australia

Oct 02, 2025

Finanzdaten der Savara Inc-Aktie (SVRA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Savara Inc-Aktie (SVRA) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
McCracken Joseph S
Director
May 29 '25
Buy
2.08
10,000
20,825
260,837
RAMSAY DAVID A
Director
Mar 31 '25
Buy
2.77
150,000
416,250
2,513,642
Lowrance David L
Chief Financial Officer
Dec 16 '24
Sale
3.33
25,000
83,278
381,005
Pauls Matthew
CHIEF EXECUTIVE OFFICER
Dec 16 '24
Sale
3.31
54,702
180,828
1,536,379
Hawkins Richard J
Director
Dec 16 '24
Sale
3.32
8,000
26,569
67,241
$21.75
price down icon 5.15%
$85.96
price up icon 1.45%
$32.75
price up icon 0.21%
$102.61
price up icon 0.30%
$161.38
price down icon 1.56%
biotechnology ONC
$320.94
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):